LOXL2 and atrial fibrillation: The current study performed a clinical study on humans and then examined Irisin’s function in Ang II-induced mice with AF vulnerability and atrial fibrosis and its potential effects on the LOXL2 and TGFβ1/Smad2/3 signaling pathways.